JP2005502640A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005502640A5 JP2005502640A5 JP2003516556A JP2003516556A JP2005502640A5 JP 2005502640 A5 JP2005502640 A5 JP 2005502640A5 JP 2003516556 A JP2003516556 A JP 2003516556A JP 2003516556 A JP2003516556 A JP 2003516556A JP 2005502640 A5 JP2005502640 A5 JP 2005502640A5
- Authority
- JP
- Japan
- Prior art keywords
- ptx3
- composition
- agent
- fertility
- female subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30947201P | 2001-08-03 | 2001-08-03 | |
| PCT/IT2002/000473 WO2003011326A1 (en) | 2001-08-03 | 2002-07-18 | Use of long pentraxin ptx3 for treating female infertility |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005502640A JP2005502640A (ja) | 2005-01-27 |
| JP2005502640A5 true JP2005502640A5 (https=) | 2006-01-05 |
| JP4312599B2 JP4312599B2 (ja) | 2009-08-12 |
Family
ID=23198379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003516556A Expired - Fee Related JP4312599B2 (ja) | 2001-08-03 | 2002-07-18 | 女性の不妊治療のための長いペントラキシンｐｔｘ３の使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20040198655A1 (https=) |
| EP (1) | EP1411971B1 (https=) |
| JP (1) | JP4312599B2 (https=) |
| KR (1) | KR100890999B1 (https=) |
| CN (1) | CN1231257C (https=) |
| AT (1) | ATE321566T1 (https=) |
| AU (1) | AU2002324328B2 (https=) |
| BR (1) | BR0211619A (https=) |
| CA (1) | CA2454421C (https=) |
| DE (1) | DE60210297T2 (https=) |
| DK (1) | DK1411971T3 (https=) |
| ES (1) | ES2261714T3 (https=) |
| HU (1) | HU228978B1 (https=) |
| MX (1) | MXPA04000909A (https=) |
| PL (1) | PL205928B1 (https=) |
| PT (1) | PT1411971E (https=) |
| WO (1) | WO2003011326A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1298487B1 (it) * | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
| ITRM20020109A1 (it) * | 2002-02-28 | 2003-08-28 | Sigma Tau Ind Farmaceuti | Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori. |
| ITRM20030595A1 (it) * | 2003-12-23 | 2005-06-24 | Sigma Tau Ind Farmaceuti | Uso della ptx3 o di un suo derivato funzionale da sola o in associazione con tsg6 per il trattamento di patologie degenarative dell'osso o della cartilagine e per il trattamento della infertilita' femminile. |
| ITRM20040489A1 (it) * | 2004-10-08 | 2005-01-08 | Sigma Tau Ind Farmaceuti | Pentraxina lunga ptx3 deglicosilata o desialidata. |
| WO2006113679A2 (en) * | 2005-04-15 | 2006-10-26 | Board Of Regents, The University Of Texas System | Delivery of sirna by neutral lipid compositions |
| US9081018B2 (en) * | 2005-12-29 | 2015-07-14 | Humanitas Mirasole S.P.A. | Diagnostic test for inflammatory endothelial dysfunctions in pregnancies |
| FR2896588B1 (fr) * | 2006-01-20 | 2016-08-19 | Univ D'angers | Methode de diagnostic in vitro de reponse immunitaire autoimmune par detection d'anticorps diriges contre l'antigene pentraxine 3. |
| PT2012816E (pt) | 2006-05-02 | 2012-08-17 | Sigma Tau Ind Farmaceuti | Uso de timosina 1, isolada ou em combinação com ptx3 ou ganciclovir, para o tratamento da infeção por citomegalovírus |
| US10162800B2 (en) | 2012-10-17 | 2018-12-25 | Celmatix Inc. | Systems and methods for determining the probability of a pregnancy at a selected point in time |
| US9177098B2 (en) | 2012-10-17 | 2015-11-03 | Celmatix Inc. | Systems and methods for determining the probability of a pregnancy at a selected point in time |
| US9836577B2 (en) | 2012-12-14 | 2017-12-05 | Celmatix, Inc. | Methods and devices for assessing risk of female infertility |
| AU2015209126A1 (en) * | 2014-01-27 | 2016-08-04 | Celmatix, Inc. | Methods for assessing whether a genetic region is associated with infertility |
| SG11201700303UA (en) | 2014-07-17 | 2017-02-27 | Celmatix Inc | Methods and systems for assessing infertility and related pathologies |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1298487B1 (it) * | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
-
2002
- 2002-07-18 US US10/485,640 patent/US20040198655A1/en not_active Abandoned
- 2002-07-18 MX MXPA04000909A patent/MXPA04000909A/es active IP Right Grant
- 2002-07-18 DE DE60210297T patent/DE60210297T2/de not_active Expired - Lifetime
- 2002-07-18 JP JP2003516556A patent/JP4312599B2/ja not_active Expired - Fee Related
- 2002-07-18 PT PT02758773T patent/PT1411971E/pt unknown
- 2002-07-18 DK DK02758773T patent/DK1411971T3/da active
- 2002-07-18 CA CA2454421A patent/CA2454421C/en not_active Expired - Fee Related
- 2002-07-18 AT AT02758773T patent/ATE321566T1/de active
- 2002-07-18 KR KR1020047001689A patent/KR100890999B1/ko not_active Expired - Fee Related
- 2002-07-18 AU AU2002324328A patent/AU2002324328B2/en not_active Ceased
- 2002-07-18 PL PL368413A patent/PL205928B1/pl not_active IP Right Cessation
- 2002-07-18 WO PCT/IT2002/000473 patent/WO2003011326A1/en not_active Ceased
- 2002-07-18 CN CNB028152948A patent/CN1231257C/zh not_active Expired - Fee Related
- 2002-07-18 EP EP02758773A patent/EP1411971B1/en not_active Expired - Lifetime
- 2002-07-18 HU HU0400662A patent/HU228978B1/hu not_active IP Right Cessation
- 2002-07-18 ES ES02758773T patent/ES2261714T3/es not_active Expired - Lifetime
- 2002-07-18 BR BR0211619-7A patent/BR0211619A/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Finke et al. | Early detection of checkpoint inhibitor-associated myocarditis using 68Ga-FAPI PET/CT | |
| JP2005502640A5 (https=) | ||
| Korosec et al. | Basophil responsiveness in patients with insect sting allergies and negative venom‐specific immunoglobulin E and skin prick test results | |
| Demedts et al. | Interstitial lung diseases: an epidemiological overview | |
| Kasperska‐Zajac | Acute‐phase response in chronic urticaria | |
| Park et al. | Adequate dextran sodium sulfate-induced colitis model in mice and effective outcome measurement method | |
| Groenning et al. | Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations | |
| Hirakata et al. | Interstitial lung disease in polymyositis and dermatomyositis | |
| Berends et al. | Biochemical and biophysical assessment of MTX‐induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan® predicts the absence of significant liver fibrosis | |
| Homma et al. | Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia? | |
| Ye et al. | Increased level of basophil CD203c expression predicts severe chronic urticaria | |
| Diepenbruck et al. | Effect of prenatal steroid treatment on the developing immune system | |
| Cuvier et al. | A first‐in‐man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM‐1 receptor inhibition | |
| Vosters et al. | Interleukin‐12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome | |
| Omma et al. | Can the thiol/disulfide imbalance be a predictor of colchicine resistance in familial Mediterranean fever? | |
| Rafikov et al. | Gender difference in damage-mediated signaling contributes to pulmonary arterial hypertension | |
| Guo et al. | The role of serum tenascin-C in predicting in-hospital death in acute aortic dissection | |
| Ehrentraut et al. | Perturbation of neddylation-dependent NF-κB responses in the intestinal epithelium drives apoptosis and inhibits resolution of mucosal inflammation | |
| US9625445B2 (en) | Compositions and methods for diagnosing and treating Sjogren's Syndrome | |
| Shewale et al. | Sarin causes autonomic imbalance and cardiomyopathy: an important issue for military and civilian health | |
| Brockow et al. | Cutaneous drug hypersensitivity: developments and controversies | |
| Shang et al. | Activation of κ‐Opioid Receptor Exerts the Glucose‐Homeostatic Effect in Streptozotocin‐Induced Diabetic Mice | |
| Riedl et al. | Insulin resistance has no impact on ghrelin suppression in pregnancy | |
| Rodriguez-Ruiz et al. | First-days reduction of plasma and skin advanced glycation end products is related to outcome in septic patients | |
| Shiel et al. | Acute binge alcohol increases risk of arrhythmias and myocardial fibrosis in a mouse model of arrhythmogenic cardiomyopathy |